Genetic prediction of medication use patterns in cardiometabolic disease
- PMID: 36683070
- DOI: 10.1038/s41591-022-02124-3
Genetic prediction of medication use patterns in cardiometabolic disease
Comment on
-
Genetic predictors of lifelong medication-use patterns in cardiometabolic diseases.Nat Med. 2023 Jan;29(1):209-218. doi: 10.1038/s41591-022-02122-5. Epub 2023 Jan 18. Nat Med. 2023. PMID: 36653479 Free PMC article.
References
-
- James, S. L. et al. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 392, 1789–1858 (2018). A review article that presents global burden of 354 disease including cardiovascular diseases. - DOI
-
- Marenberg, M. E., Risch, N., Berkman, L. F., Floderus, B. & de Faire, U. Genetic susceptibility to death from coronary heart disease in a study of twins. New Engl. J. Med. 330, 1041–1046 (1994). This paper reports heritability estimates for coronary heart disease. - DOI
-
- SEARCH Collaborative Group. SLCO1B1 variants and statin-induced myopathy—a genomewide study. New Engl. J. Med. 359, 789–799 (2008). A review article that presents evidence for adverse reactions to statin use for individuals carrying risk variants in the SLCO1B1 gene. - DOI
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources